Genetic variation shapes brain structure, but whether that neuroanatomical expression of genotype is reflected in circulating proteomic profiles is unclear. The authors adapted a lab‑developed method that creates individual‑level, SNP‑specific brain‑genotype scores learned directly from whole‑brain structural MRI. They hypothesized that these neuroanatomically derived genetic representations would capture biologically meaningful variation in plasma protein levels that conventional genotype models do not.
Analyses used the UK Biobank resource under Application Number 15181. The report states that all relevant ethical guidelines were followed, participant consent was obtained, and necessary institutional approvals or exemptions were in place. The authors declared no competing interests. Data produced in the study are available on reasonable request to the authors.
The primary methodological innovation is the use of brain‑genotype scores, an approach previously developed in the authors' laboratory. These scores provide SNP‑specific, individual‑level representations of how genotype is expressed across neuroanatomy by learning associations between single nucleotide polymorphisms and whole‑brain structural MRI features. The present study adapted these representations for proteomic association testing, enabling direct integration of genetic, neuroimaging, and proteomic data within the same individuals. The source text does not provide additional technical details of score construction in this summary; those specifics were not reported in the source material provided.
Using UK Biobank participants with available data, the investigators tested associations between 120 brain‑genotype scores and plasma levels of 2,920 proteins. Statistical testing included correction for multiple comparisons using false discovery rate (FDR). After FDR correction, they identified 116 significant genomic‑neuroimaging‑proteomic associations involving 49 distinct brain‑genotype scores and 52 proteins. The source text does not report individual protein names, effect sizes, p values, or covariates used in the models; those details were not reported in the source material provided.
The authors compared results from brain‑genotype scores with conventional SNP dosage models. None of the 116 significant associations detected by the brain‑genotype scores were detected using conventional SNP dosage analyses. Moreover, the brain‑genotype scores explained substantially more variance in protein levels than genotype alone, indicating that the neuroanatomical representation added explanatory power beyond standard genetic models.
To assess biological coherence, enrichment analyses were performed on the proteins associated with brain‑genotype scores. These analyses identified convergent pathways related to immune, metabolic, signalling, and cell‑cycle processes. Tissue enrichment analysis implicated multiple organs and regions, including brain, liver, pancreas, and hypothalamus. The source does not provide the specific enrichment statistics, pathway names, or gene sets used; those specifics were not reported in the source material provided.
Several of the proteins identified in the analysis overlapped with prior imaging‑proteomic literature, which the authors cite as supporting the biological plausibility of the observed associations. This concordance suggests that neuroanatomically derived genetic representations may capture mechanisms that influence both brain structure and circulating proteomic markers. The summary does not enumerate the overlapping proteins or prior studies referenced.
The summary emphasizes that integrating genetic, neuroimaging, and proteomic data within the same individuals is methodologically challenging; the brain‑genotype score approach is presented as a solution that reveals associations not found by conventional genotype modeling. The authors conclude that brain‑genotype scores reveal biologically meaningful proteomic variation beyond conventional genotype analyses and provide a framework to link genetic variation, brain structure, and the circulating proteome.
The source statement indicates that all data produced are available upon reasonable request. The study was conducted using UK Biobank data and funding included Alzheimer’s Research UK and King Abdulaziz University as declared. Specific methodological parameters, individual protein identities, effect sizes, and full enrichment statistics were not reported in the source summary provided here.